60+ OR IN YOUR 50s AT INCREASED RISK?* PROTECT AGAINST RSV WITH

Both people 60+ and those in their 50s at increased risk* can be protected against RSV with AREXVY

*Increased risk includes people with conditions like respiratory, liver, cardiovascular, or kidney disease, or diabetes

AREXVY was proven effective in a large study with people 60+ years old.

OVER82%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older

OVER94%

EFFECTIVE

in preventing lung and lower airway infection from RSV in people aged 60 years and older with asthma, diabetes, chronic obstructive pulmonary disease (COPD), chronic heart failure, advanced liver or kidney disease, or any chronic respiratory or pulmonary disease

What Is RSV?

RSV is a contagious respiratory virus. It can lead to severe infections affecting the lungs and lower airways.

About RSV

What Is AREXVY?

AREXVY is an FDA-approved vaccine used to prevent lung and lower airway infection caused by RSV in people 60 years and older or those 50 through 59 years old at increased risk.

About AREXVY

Is AREXVY for Me?

See sample questions to ask your doctor about RSV and getting vaccinated.

GET STARTED

AREXVY is #1 in RSV vaccine shots* *Retail claims of doses given to adults 60+ July 2023-September 2024; retail making up majority of RSV market

*Retail claims of doses given to adults 60+ July 2023-December 2024; retail making up majority of RSV market.

Location pin icon

GET AREXVY

See when and where you can get AREXVY.

FIND AREXVY

Hand icon

GET VACCINE REMINDERS

Sign up for reminders about getting AREXVY.

REMIND ME

Information icon

STAY INFORMED

Sign up for more information about RSV and AREXVY.